Bayer Group SWOT Analysis, Competitors & USP

Published by MBA Skool Team, Last Updated: April 12, 2020

SWOT analysis of Bayer Group analyses the brand by its strengths, weaknesses, opportunities & threats. In Bayer Group SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like Bayer Group to benchmark its business & performance as compared to the competitors. Bayer Group is one of the leading brands in the industrial products and chemicals sector.

The table below lists the Bayer Group SWOT (Strengths, Weaknesses, Opportunities, Threats), top Bayer Group competitors and includes its target market, segmentation, positioning & Unique Selling Proposition (USP).

Bayer Group SWOT Analysis, Competitors, Segmentation, Target Market, Positioning, USP & Brand Analysis Table
Bayer Group Brand Analysis
Parent Company

Bayer group


Diversified Chemical


Industrial Products and Chemicals

Tagline/ Slogan

Science for a better life


Innovative pharmaceutical products like genetically engineered product

Bayer Group STP

Health Care segment, Agriculture, Polymers and Chemicals segments

Target Group

Analgesics, cardiovascular risk prevention, cough & cold, dermatology, gastrointestinal and nutritionals health care, animal health care, Seed treatment and pest prevention


Worldwide leading position in therapeutic drugs area

SWOT Analysis of Bayer Group
Bayer Group Strengths

Below are the Strengths in the SWOT Analysis of Bayer Group:

1. Comprehensive portfolio of chemical, material science, healthcare and agricultural products

2. Bayer remains vastly dominant in pediatric vitamins and dietary supplements with 25% value share

3. Diversified supply process in conjunction with long-term supply agreements minimize the company’s exposure to production process risk

4. Presence in diversified streams offers protection against demand fluctuations

5. Strong brand presence in the industry and strong financials

Bayer Group Weaknesses

Here are the weaknesses in the Bayer Group SWOT Analysis:

1. Allegations against the group on price fixing has tarnished the brand image

2. Shown in bad light over patent infringements and lawsuits

3. Biotech products segment affected by risk due to highly complex manufacturing process

Bayer Group Opportunities

Following are the Opportunities in Bayer Group SWOT Analysis:

1. High potential drugs like Xarelto, Stivarga, Eylea, Xofigo &Riociguat

2. Joint ventures and acquisitions will increase market presence

3. Growing demand in crop industry

Bayer Group Threats

The threats in the SWOT Analysis of Bayer Group are as mentioned:

1. Weak global economy and problems in pharmaceutical industries can hamper growth

2. Bayer's revenue growth may be impacted negatively by Regulatory controls on pharmaceutical product prices

3. Low cost substitutes

Bayer Group Competition
Bayer Group Competitors

Below are the top 5 competitors of Bayer Group:

1. GlaxoSmithKline Plc.

2. Johnson & Johnson

3. Abbott Laboratories

4. Novartis AG

5. Pfizer Inc.

This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to Bayer Group. This section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2500 brands from over 20 industry sectors.

Continue Reading:

The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute

Share this Page on:
Facebook ShareTweetShare on Linkedin